Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2014
06/05/2014WO2014052717A3 Cd20-and egfr-binding proteins enhanced stability
06/05/2014WO2014039975A3 Anti-mcam antibodies and associated methods of use
06/05/2014WO2014037899A3 Il-18 binding molecules
06/05/2014WO2014036412A3 A method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
06/05/2014WO2014026054A3 CD20 scFv-ELPs METHODS AND THERAPEUTICS
06/05/2014WO2013154206A9 Anti-fgfr2 antibody
06/05/2014US20140155678 Focused radiation for augmenting immune-based therapies against neoplasms
06/05/2014US20140155579 Dual specificity antibodies and methods of making and using
06/05/2014US20140155288 Methods for diagnosing cancer
06/05/2014US20140154329 Process For Stabilizing An Adjuvant Containing Vaccine Composition
06/05/2014US20140154315 Hydrophobic Preparations
06/05/2014US20140154307 Inhibition of factor b, the alternative complement pathway and methods related thereto
06/05/2014US20140154289 Attenuated plasmodium with deactivated hmgb2 gene, as vaccine
06/05/2014US20140154288 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
06/05/2014US20140154285 Fusion proteins for use as immunogenic enhancers for inducing antigen-specific t cell responses
06/05/2014US20140154284 Methods and compositions for inhibiting polyomavirus-associated pathology
06/05/2014US20140154282 Conjugates utilizing platform technology for stimulating immune response
06/05/2014US20140154281 Mphosph1 peptides and vaccines including the same
06/05/2014US20140154278 Method for allogeneic cell therapy
06/05/2014US20140154274 Methods and compositions for use in intralymphatic cellular therapies
06/05/2014US20140154265 Arterivirus
06/05/2014US20140154263 Use of TAK1 Inhibitor to Achieve Glycemic Control in Mammals
06/05/2014US20140154262 Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
06/05/2014US20140154261 Pharmaceutical composition for treatment and/or prophylaxis of cancer
06/05/2014US20140154260 B-7 related nucleic acids and polypeptides useful for immunomodulation
06/05/2014US20140154259 Method for the treatment of inflammatory disorders
06/05/2014US20140154257 Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents
06/05/2014US20140154246 Cai-based systems and methods for the localized treatment of ocular and other diseases
06/05/2014US20140154243 Specific binding agents to hepatocyte growth factor
06/05/2014US20140154242 Immunoglobulin variants and uses thereof
06/04/2014EP2738253A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
06/04/2014EP2737907A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
06/04/2014EP2737906A1 Therapeutic vaccines
06/04/2014EP2737059A1 Novel prrs virus inducing type i interferon in susceptible cells
06/04/2014EP2737058A1 INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
06/04/2014EP2736922A1 Prevention of salmonella recrudescense
06/04/2014EP2736537A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
06/04/2014EP2736534A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab
06/04/2014EP2736532A2 Compositions and methods for improving potency and breadth or hiv antibodies
06/04/2014EP2736531A2 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
06/04/2014EP2736530A1 Use of il-12 to generate endogenous erythropoietin
06/04/2014EP2736529A2 Stabilized formulations containing anti-pcsk9 antibodies
06/04/2014EP2736528A1 Compositions and methods for the treatment of hiv
06/04/2014EP2736527A1 Dendritic cell (dc)-vaccine therapy for pancreatic cancer
06/04/2014EP2736526A1 Use of epitopes inducing specific tolerance for the prevention of tissue rejection
06/04/2014CN1867667B Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
06/04/2014CN103842383A Multi-specific fab fusion proteins and methods of use
06/04/2014CN103842382A Antibody polypeptides that antagonize CD40
06/04/2014CN103842381A An antibody inducing antigen-specific t cell tolerance and use thereof
06/04/2014CN103842030A Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
06/04/2014CN103842029A Attenuated plasmodium with deactivated HMGB2 gene, as vaccine
06/04/2014CN103841993A Human enterovirus specific antibodies and their uses in diagnostics
06/04/2014CN103841992A Methods of treating or preventing cholesterol related disorders
06/04/2014CN103841989A Submicron particles to decrease transfusion
06/04/2014CN103834687A Preparation method of periodic Wuchereria malayi compound polyvalent protein vaccine
06/04/2014CN103834669A Oral vaccine of streptococcus agalactiae and preparation method thereof
06/04/2014CN103834620A Newcastle disease virus, newcastle disease inactivated vaccine and preparation method of newcastle disease inactivated vaccine
06/04/2014CN103834619A Duck virus hepatitis virus, duck virus hepatitis inactivated vaccine and preparation method of duck virus hepatitis inactivated vaccine
06/04/2014CN103834617A Human enterovirus 71-type C4-subtype lethal strain SD095 and its application
06/04/2014CN103833865A Method for preparing streptococcus pneumoniae capsular polysaccharide
06/04/2014CN103833854A Immunoglobulin variants and uses thereof
06/04/2014CN103833853A Novel death receptor agonistic polyvalent antibody, and application thereof in preparing anti-tumor drug
06/04/2014CN103833852A Bispecific antibody aiming at phosphatidylinositols protein polysaccharide-3 and T cell antigen
06/04/2014CN103833830A Conservative neutralizing epitope polypeptide of Coxsackievirus A16 and application thereof
06/04/2014CN103830747A Genetically engineered vaccine of epsilon toxin of clostridium perfringens and application thereof
06/04/2014CN103830746A Riemerella anatipestifer deoxyribonucleic acid (DNA) vaccine based on OmpA (octamethyl pyrophosphoramide) gene and preparation method of vaccine
06/04/2014CN103830725A Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/04/2014CN103830724A Muscovy duck parvovirus inactivation vaccine and application thereof
06/04/2014CN103830723A Preparation method of streptococcus pneumoniae capsular polysaccharide protein conjugate vaccine
06/04/2014CN103830722A Clostridium perfringens beta toxin genetic engineering vaccine and application thereof
06/04/2014CN103830721A Derivant of establishing rheumatoid arthritis animal model, preparation and application thereof
06/04/2014CN103214556B Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MAT1 (Metastasis Associated Gene1) and application thereof
06/04/2014CN103159858B Swine fever branch peptide and application thereof
06/04/2014CN103131719B Taenia multiceps enolase TmENO recombinant protein with immunizing protection
06/04/2014CN102965332B Swine testicular clone cell line and production method of classical swine fever live vaccine
06/04/2014CN102796710B Non-pathogenic recombinant attenuated rabies virus strain and construction method and application thereof
06/04/2014CN102784390B Method for preparing thermal-stability vaccine
06/04/2014CN102776155B Chinese isolated strain of bovine enterovirus, and construction and application of infectious cDNA clone thereof
06/04/2014CN102649816B Application of high mobility group box (HMGB) protein and antibody to preparation of ostrea rivularis anti-infection immune preparation
06/04/2014CN102649815B Application of AIF1 (Allograft Inflammatory Factor 1) protein and antibody to preparing southern oyster anti-infectious immune preparation
06/04/2014CN102618508B Recombinant porcine pseudorabies virus, as well as construction method and application thereof
06/04/2014CN102614503B Edwardsiella tarda recombinant protein vaccines, and preparation and application thereof
06/04/2014CN102558348B Single-chain antibody for resisting influenza viruses, preparation method for single-chain antibody, application of single-chain antibody
06/04/2014CN102552910B Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases
06/04/2014CN102488898B Carious tooth vaccine and preparation method
06/04/2014CN102485749B Swine fever synthesized peptide vaccine and preparation method thereof
06/04/2014CN102448987B Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody
06/04/2014CN102307995B Transformed soybean plant which stores vaccine, and use thereof
06/04/2014CN102206256B HCV envelope protein E2 with deleting hypervariable region 1 and use thereof
06/04/2014CN102167740B Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof
06/04/2014CN101926988B Injectable vaccines against multiple meningococcal serogroups
06/04/2014CN101780080B Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
06/04/2014CN101711164B Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
06/04/2014CN101613409B PDGFR-alpha antibody
06/04/2014CN101300028B Live attenuated rotavirus vaccine for oral administration
06/03/2014US8742090 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
06/03/2014US8742087 Mucin antigen vaccine
06/03/2014US8742076 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
06/03/2014US8742075 Monoclonal antibodies against ANGPTL3
06/03/2014US8741876 Therapeutic agent for ulcerative colitis
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 1823